NEW DELHI--(BUSINESS WIRE)--Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, presented two ...
NEW DELHI--(BUSINESS WIRE)--Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines for treating diseases caused by drug-resistance in the skin microbiome, ...